BioVie Inc. - Common stock — Quarterly Cash Flow (NASDAQ:BIVI) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 21.56 M26.82 M22.5 M17.51 M Total liabilities 2.55 M1.9 M3.24 M1.91 M Total equity 19.01 M24.92 M19.27 M15.61 M Total liabilities & shareholders' equities 21.56 M26.82 M22.5 M17.51 M Total debt ———— Net debt ————

News

BioVie Inc. (BIVI) Discusses Bezisterim's Mechanism of Action and Its Potential in Addressing Parkinson's Disease Pathology Transcript

BioVie Inc. (BIVI) Discusses Clinical Progress of Bezisterim Targeting Inflammation in Parkinson's, Alzheimer's, and Long COVID Transcript

BioVie completes enrollment for Parkinson’s drug trial

What Makes BioVie (BIVI) a New Buy Stock

BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease Transcript

BioVie Inc. (BIVI) Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease - Slideshow (NASDAQ:BIVI) 2025-12-09

BioVie shareholders approve amendment to equity incentive plan at annual meeting

BioVie shareholders approve board nominees and equity plan at annual meeting

Akari Therapeutics appoints Kameel Farag as interim CFO

BioVie Inc. - Special Call

BioVie closes $12 million public offering of units

Why Is BioVie Stock (BIVI) Down 50% Today? - TipRanks.com